[March 05, 2015]

Research and Markets: Epilepsy Therapeutics Pipeline Review 2015 - Featuring 52 Companies

Research and Markets (http://www.researchandmarkets.com/research/tfq8wx/epilepsy) has announced the addition of the "Epilepsy - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late-stage and discontinued projects.

The report enhances decisin making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Acorda Therapeutics, Inc.
• Adamas Pharmaceuticals, Inc.
• Advicenne Pharma
• Aeolus Pharmaceuticals, Inc.
• Aestus Therapeutics, Inc.
• Alexza Pharmaceuticals, Inc.
• Allergan, Inc.
• Anavex Life Sciences Corp.
• Asklepios BioPharmaceutical, Inc.
• Astellas Pharma Inc.
• Bial - Portela & Ca, S.A.
• BioCrea GmbH
• Bionomics Limited
• Biovista Inc.
• Catalyst Pharmaceutical Partners, Inc.
• Celentyx Ltd.
• Chong Kun Dang Pharmaceutical Corp.
• Concert Pharmaceuticals, Inc.
• Convergence (News - Alert) Pharmaceuticals Ltd.
• D-Pharm Ltd.
• Desitin Arzneimittel GmbH
• Eisai Co., Ltd.
• Epirus Biopharmaceuticals, Inc.
• Glialogix, Inc.
• GW Pharmaceuticals plc
• H. Lundbeck A/S
• INSYS Therapeutics, Inc.
• Iproteos S.L.
• Knopp Biosciences LLC
• Ligand Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/tfq8wx/epilepsy

[ Back To TMCnet.com's Homepage ]